Based in Boston, Massachusetts, The John Merck Fund was established in 1970 by the late Serena Merck and is now in its third generation of family leadership. Starting in 2012, The John Merck Fund will spend all of its assets over the next ten years to spur progress in clean energy, environmental health, development of a New England regional food system, and treatment of developmental disabilities. The John Merck Fund will award its last grants in 2021 and close its doors in 2022.
The Clean Energy Program promotes the development of a clean-energy economy in the six-state New England region. Specifically, the program will seek improved air quality and a ten-year, region-wide greenhouse-gas emissions reduction of 20 percent by supporting projects to boost energy efficiency, reduce use of coal and other fossil fuels, and expand New England's clean energy market.
The Environmental Health Program supports development and implementation of market signals and government policies that encourage a transition away from petroleum-based chemicals linked to preventable diseases.
The Regional Food Systems Program helps strengthen innovation and entrepreneurship in New England's expanding market for regionally and sustainably grown food by funding initiatives to develop institutional demand and the regional supply network.
The Developmental Disabilities Program, the Fund's original grantmaking area, is shifting its focus from basic research to clinical and translational research, with primary emphasis on children who have Fragile X or Down syndromes. The goal is to help these children and their families by encouraging research collaborations that bridge basic and clinical science, more rapid translation of findings into treatment settings, and promulgation of best clinical practices.
Dr. Frederica Perera wins the Heinz Award for the Environment, click here for details .
Click here to read the press release about JMF "Sparkplug" Dr. Bradley Schlaggar , Professor of Neurology at Washington University School of Medicine in St. Louis.
To learn the recipients of our recent Translational Research Program awards, click here.
The John Merck Fund will spend out all its assets between 2012 and 2022.
To learn more
about this decision, click here.